Medical Devices Market in China to 2018 - Government Reforms Aimed at Strengthening the Healthcare System and Expanding Access will Accelerate Growth

Introduction

China's huge and increasingly elderly population, some remotely situated in rural areas, will be provided with strong healthcare infrastructure, states a new report by healthcare experts GBI Research.

The rising incidence of chronic and infectious diseases in this vast country serves to benefit both patients and medical device companies, who may supply China's government to meet their new healthcare reforms.

The healthcare reform initiative known as ‘Opinions on Deepening the Health Care System Reform', or the ‘New Health Care Reform Plan', is being implemented by the Chinese State Council and the Communist Party of China (CPC) Central Committee, and represents a major driving factor for the healthcare sector in China. The reforms aim to provide health services for both the urban and rural population.

Healthcare infrastructure improvements are expected to drive market growth for both international and domestic companies, due to improved affordability and accessibility to healthcare services within a growing number of hospitals. New insurance policies aiming to increase the reimbursement ratio for a number of diseases will also lead to an expanding patient base.

Chronic diseases go hand in hand with elderly populations and demand significant medical support. An increasing life expectancy is leading to a growing incidence of ophthalmic diseases, as the elderly population has a high percentage of patients suffering from cataracts, with a large number of cases being added annually. Despite the large patient pool, China displays a low Cataract Surgery Rate (CSR), due to high costs, limited public awareness, and a lack of facilities in rural areas. However, the implementation of government-backed insurance schemes will increase reimbursement for medical treatment, and a significant demand is expected to be seen for ophthalmic surgery devices.

Infectious diseases can also become more common in developing countries, as populations become more urbanized and live in closer quarters to one another. China's medical devices market is dominated by In Vitro Diagnostics (IVD) and driven by a large patient pool that requires large volumes of tests - especially amidst rising cases of infectious diseases, which claimed nearly 15,802 lives in 2011. Improving the affordability of IVD products in China through new healthcare reforms is expected to boost the market.

Rapid urbanization and economic development has also resulted in lifestyle and nutritional changes, which have caused an increase in the incidence of conditions such as diabetes and cardiovascular diseases, which require diagnostic testing and monitoring.

The medical devices market in China is forecast to grow at a Compound Annual Growth Rate (CAGR) of 11%, from $14.3 billion in 2011 to reach $30.4 billion in 2018.

*Medical Devices Market in China to 2018 - Government Reforms Aimed at Strengthening the Healthcare System and Expanding Access will Accelerate Growth

This report provides key data, information and analysis on the medical devices market in China, giving market landscape, competitive landscape and market trends information on ten medical devices markets: ophthalmic devices, In Vitro Diagnostics (IVD), diagnostic imaging, cardiovascular devices, nephrology and urology devices, orthopedic devices, drug delivery devices, diabetes care devices, wound care management, and healthcare IT. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. It also reviews the competitive landscape, gives a detailed analysis of the pipeline products in each market, and reviews details regarding important merger and acquisition deals.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

Table of Contents

1. Table of Contents

• 1.1. List of Tables
• 1.2. List of Figures

2. Executive Summary

• 2.1. The Medical Devices Market in China is Forecast to Increase at a CAGR of 11% During 2011 - 2018
• 2.2. Healthcare Reforms in China: A Major Driving Force behind China's Healthcare Sector
• 2.3. The Ophthalmic Devices and In Vitro Diagnostics Sectors are the Largest in the Medical Devices Market in China

3. Introduction

• 3.1. GBI Research Report Guidance

4. Medical Devices Market in China: Overview

5. Medical Devices Market, China: Market Characterization

• 5.1. Medical Devices Market, China, Revenue ($m), 2004 - 2011
• 5.2. Medical Devices Market, China, Revenue ($m), 2011 - 2018
• 5.3. Medical Devices Market, China: Market Dynamics

6. Regulatory Policies for Medical Devices in China

7. Healthcare Reforms in China

• 7.1.1. Establishment of a Basic Medical Security System
• 7.1.2. Establishment of the National Essential Drug List (EDL)
• 7.1.3. Construction of Primary Healthcare Services Encouraged
• 7.1.4. Public Health Services Improved
• 7.1.5. Hospital Reform Policies Established
• 7.1.6. The 12th Five Year Plan

8. Ophthalmic Devices Market, China: Market Characterization

• 8.1. Ophthalmic Devices Market, China, Revenue ($m), 2004 - 2011
• 8.2. Ophthalmic Devices Market, China, Revenue ($m), 2011 - 2018
• 8.3. Ophthalmic Devices Market, China, Key Company Share (%), 2010
• 8.4. Ophthalmic Devices Market, China: Market Dynamics

9. In Vitro Diagnostics Market, China: Market Characterization

• 9.1. In Vitro Diagnostics Market, China, Revenue ($m), 2004 - 2011
• 9.2. In Vitro Diagnostics Market, China, Revenue ($m), 2011 - 2018
• 9.3. In Vitro Diagnostics Market, China, Key Company Share (%), 2010
• 9.4. In Vitro Diagnostics Market, China: Market Dynamics

10. Diagnostic Imaging Market, China: Market Characterization

• 10.1. Diagnostic Imaging Market, China, Revenue ($m), 2004 - 2011
• 10.2. Diagnostic Imaging Market, China, Revenue ($m), 2011 - 2018
• 10.3. Diagnostic Imaging Market, China, Key Company Share (%), 2011
• 10.4. Diagnostic Imaging Market, China - Market Dynamics

11. Cardiovascular Devices Market, China: Market Characterization

• 11.1. Cardiovascular Devices Market, China, Global, Revenue ($m), 2004 - 2011
• 11.2. Cardiovascular Devices Market, China, Revenue ($m), 2011 - 2018
• 11.3. Cardiovascular Devices Market, China, Key Company Share (%), 2011
• 11.4. Cardiovascular Devices Market: Market Dynamics

12. Nephrology and Urology Devices Market, China: Market Characterization

• 12.1. Nephrology and Urology Devices Market, China, Revenue ($m), 2004 - 2011
• 12.2. Nephrology and Urology Devices Market, China, Revenue ($m), 2011 - 2018
• 12.3. Nephrology and Urology Devices Market, China, Key Company Share (%), 2011
• 12.4. Nephrology and Urology Devices Market, China: Market Dynamics

13. Orthopedic Devices Market, China: Market Characterization

• 13.1. Orthopedic Devices Market, China, Revenue ($m), 2004 - 2011
• 13.2. Orthopedic Devices Market, China, Revenue ($m), 2011 - 2018
• 13.3. Orthopedic Devices Market, China, Key Company Share (%), 2011
• 13.4. Orthopedic Devices Market, China: Market Dynamics

14. Drug Delivery Devices Market, China: Market Characterization

• 14.1. Drug Delivery Devices Market, China, Revenue ($m), 2004 - 2011
• 14.2. Drug Delivery Devices Market, China, Revenue ($m), 2011 - 2018
• 14.3. Drug Delivery Devices Market, China, Key Company Share (%), 2010
• 14.4. Drug Delivery Devices Market, China - Market Dynamics

15. Diabetes Care Devices Market, China: Market Characterization

• 15.1. Diabetes Care Devices Market, China, Revenue ($m), 2004 - 2011
• 15.2. Diabetes Care Devices Systems Market, China, Revenue ($m), 2011 - 2018
• 15.3. Diabetes Care Devices Market, China, Key Company Share (%), 2011
• 15.4. Diabetes Care Devices Market, China: Market Dynamics

16. Wound Care Management Market, China: Market Characterization

• 16.1. Wound Care Management Market, China, Revenue ($m), 2004 - 2011
• 16.2. Wound Care Management Market, China, Revenue ($m), 2011 - 2018
• 16.3. Wound Care Management Market, China, Key Company Share (%), 2010
• 16.4. Wound Care Management Market, China: Market Dynamics

17. Healthcare IT Market, China: Market Characterization

• 17.1. Healthcare IT Market, China, Revenue ($m), 2004 - 2011
• 17.2. Healthcare IT Market, China, Revenue ($m), 2011 - 2018
• 17.3. Healthcare IT Market, China, Key Company Share (%), 2011
• 17.4. Healthcare IT Market, China: Market Dynamics

18. Medical Devices Market, China: Market Assessment

• 18.1. International Companies
  • 18.1.1. Siemens Healthcare
  • 18.1.2. Fresenius Medical Care AG & Co. KGaA
  • 18.1.3. GE Healthcare
  • 18.1.4. F. Hoffmann-La Roche Ltd.
  • 18.1.5. Philips Healthcare
  • 18.1.6. Essilor International
  • 18.1.7. DePuy, Inc.
  • 18.1.8. Medtronic, Inc.
  • 18.1.9. Boston Scientific Corporation
• 18.2. Domestic Companies
  • 18.2.1. Mindray Medical International Limited
  • 18.2.2. Shandong Weigao Group Medical Polymer
  • 18.2.3. WuHan VSD Medical Science & Technology Co. Ltd.
  • 18.2.4. Neusoft Medical Systems Co., Ltd.

19. Medical Devices Market, China: Product Pipeline Analysis

• 19.1. Medical Devices Market, China - Product Pipeline Summary
• 19.2. Medical Devices Market, China: Product Pipeline
  • 19.2.1. Medical Devices Market, China: Profiles of Key Pipeline Products
  • 19.2.2. Medical Devices Market, China: List of Pipeline Products

20. Medical Devices Market, China: Consolidation Landscape

• 20.1. Key Deals: 2007 - 2011
  • 20.1.1. Biosensors' Acquisition of the Remaining 50% Interest in JW Medical Systems from Shandong Weigao Group
  • 20.1.2. Fresenius Medical Care's Acquisition of Peritoneal Dialysis Business from Gambro
  • 20.1.3. Lepu Medical Technology Acquires Beijing Star Medical Devices
  • 20.1.4. Royal Philips Electronics' Acquisition of Mammography Equipment Product Line from Sectra
  • 20.1.5. Royal Philips Electronics' Acquisition of Shanghai Apex Electronics Technology
  • 20.1.6. bioMerieux's Acquisition Of Meikang Biotech (Shanghai)
  • 20.1.7. Fujifilm Acquires Tianjian Medi Tech
• 20.2. Key Partnerships: 2007 - 2011
  • 20.2.1. Weihai Weigao Blood Purified Product Company's Joint Venture with Nikkiso
  • 20.2.2. Medtronic's Joint Venture Agreement With Shandong Weigao Group Medical Polymer Company
  • 20.2.3. Shinva Medical Instrument's Joint Venture with GE Healthcare

21. Appendix

• 21.1. Definitions
  • 21.1.1. Ophthalmic Devices
  • 21.1.2. In Vitro Diagnostics
  • 21.1.3. Diagnostic Imaging
  • 21.1.4. Cardiovascular Devices
  • 21.1.5. Nephrology and Urology Devices
  • 21.1.6. Orthopedic Devices
  • 21.1.7. Drug Delivery Devices
  • 21.1.8. Diabetes Care Devices
  • 21.1.9. Wound Care Management
  • 21.1.10. Healthcare IT
• 21.2. Acronyms
• 21.3. Sources
• 21.4. Research Methodology
  • 21.4.1. Secondary Research
  • 21.4.2. Primary Research
  • 21.4.3. Models
  • 21.4.4. Forecasts
  • 21.4.5. Expert Panels
• 21.5. Contact Us
• 21.6. Disclaimer

• Figure 1: Medical Devices Market, China, Revenue ($bn), 2011 - 2018
• Figure 2: Medical Devices Market, China, Impact of Healthcare Reforms, Benefits and Limitations
• Figure 3: Medical Devices Market, China, Largest Sectors, 2012
• Figure 4: Medical Devices Market, China, Classification of Medical Devices
• Figure 5: Medical Devices Market, China, Revenue ($m), 2004 - 2011
• Figure 6: Medical Devices Market, China, Revenue ($m), 2011 - 2018
• Figure 7: China Population (billion), 2005 - 2025
• Figure 8: Total Population (million), Urban and Rural Regions, China, 2009
• Figure 9: Total Health Expenditure Per Capita and Healthcare Expenditure as % of Total Government Expenditure, 2009
• Figure 10: Sources of Healthcare Financing (%), China, 2000 - 2010
• Figure 11: Registration Process for Domestic and Imported Medical Products, China, 2011
• Figure 12: Registration Process for Imported Medical Products, China, 2011
• Figure 13: Population with Basic Healthcare Coverage (%), China, 2000 and 2011
• Figure 14: Basic Health Insurance Programs in China
• Figure 15: Healthcare Institutions, China, Structure and Facilities
• Figure 16: Number of Healthcare Institutions (‘000), China, 2003 - 2009
• Figure 17: Medical Devices Market, China, 12th Five Year Plan (FYP), 2011
• Figure 18: Ophthalmic Devices Market, China, Revenue ($m), 2004 - 2011
• Figure 19: Ophthalmic Devices Market, China, Revenue ($m), 2011 - 2018
• Figure 20: Ophthalmic Devices Market, China, Key Company Share (%), 2010
• Figure 21: Ophthalmic Devices Market, China, Expected Intra Ocular Lenses Volume (Absolute Units), 2010 - 2016
• Figure 22: In Vitro Diagnostics Market, China, Revenue ($m), 2004 - 2011
• Figure 23: In Vitro Diagnostics Market, China, Revenue ($m), 2011 - 2018
• Figure 24: In Vitro Diagnostics Market, China, Key Company Share (%), 2010
• Figure 25: Diagnostic Imaging Market, China, Revenue ($m), 2004 - 2011
• Figure 26: Diagnostic Imaging Market, China, Revenue ($m), 2011 - 2018
• Figure 27: Diagnostic Imaging Market, China, Key Company Share (%), 2011
• Figure 28: Diagnostic Imaging Market*, China, Expected Volume (Absolute Units), 2011 - 2018
• Figure 29: Cardiovascular Devices Market, China, Revenue ($m), 2004 - 2011
• Figure 30: Cardiovascular Devices Market, China, Revenue ($m), 2011 - 2018
• Figure 31: Cardiovascular Devices Market, China, Key Company Share (%), 2011
• Figure 32: Cardiovascular Devices Market, China, Cardiovascular Procedures, PCI Procedures, Expected Procedural Volume (‘000), 2008 - 2015
• Figure 33: Nephrology and Urology Devices Market, China, Revenue ($m), 2004 - 2011
• Figure 34: Nephrology and Urology Devices Market, China, Revenue ($m), 2011 - 2018
• Figure 35: Nephrology and Urology Devices Market, China, Key Company Share (%), 2011
• Figure 36: Nephrology and Urology Devices Market, China, Market Categorization, 2010
• Figure 37: Orthopedic Devices Market, China, Revenue ($m), 2004 - 2011
• Figure 38: Orthopedic Devices Market, China, Revenue ($m), 2011 - 2018
• Figure 39: Orthopedic Devices Market, China, Key Company Share (%), 2011
• Figure 40: Orthopedic Devices Market, China, Key Categories (%), 2011 - 2018
• Figure 41: Orthopedic Devices Market, China, Orthopedic Procedures, Joint Replacement of Lower Extremity, Expected Procedural Volume (‘000), 2011 - 2016
• Figure 42: Drug Delivery Devices Market, China, Revenue ($m), 2004 - 2011
• Figure 43: Drug Delivery Devices Market, China, Revenue ($m), 2011 - 2018
• Figure 44: Drug Delivery Devices Market, China, Key Company Share (%), 2010
• Figure 45: Drug Delivery Devices Market, China, Volume (Absolute Units), 2011 - 2016
• Figure 46: Diabetes Care Devices Market, China, Revenue ($m), 2004 - 2011
• Figure 47: Diabetes Care Devices Market, China, Revenue ($m), 2011 - 2018
• Figure 48: Diabetes Care Devices Market, China, Key Company Share (%), 2011
• Figure 49: Wound Care Management Market, China, Revenue ($m), 2004 - 2011
• Figure 50: Wound Care Management Market, China, Revenue ($m), 2011 - 2018
• Figure 51: Wound Care Management Market, China, Key Company Share (%), 2010
• Figure 52: Healthcare IT Market, China, Revenue ($m), 2004 - 2011
• Figure 53: Healthcare IT Market, China, Revenue ($m), 2011 - 2018
• Figure 54: Healthcare IT Market, China, Key Company Share (%), 2011
• Figure 55: Medical Devices Market, China, Market Assessment, 2011
• Figure 56: Medical Devices Market, China, Opportunities and Challenges for International and Domestic Players

• Table 1: Medical Devices Market, China, Revenue ($m), 2004 - 2011
• Table 2: Mortality Rate Due to 10 Major Diseases in China, Urban Regions, 2009
• Table 3: Medical Devices Market, China, Revenue ($m), 2011 - 2018
• Table 4: Ophthalmic Devices Market, China, Revenue ($m), 2004 - 2011
• Table 5: Ophthalmic Devices Market, China, Revenue ($m), 2011 - 2018
• Table 6: Ophthalmic Devices Market, China, Key Company Revenue ($m), 2010
• Table 7: Ophthalmic Diseases and Blindness, China, Disease Incidence, 2012
• Table 8: In Vitro Diagnostics Market, China, Revenue ($m), 2004 - 2011
• Table 9: In Vitro Diagnostics Market, China, Revenue ($m), 2011 - 2018
• Table 10: In Vitro Diagnostics Market, China, Key Company Revenue ($m), 2010
• Table 11: Diagnostic Imaging Market, China, Revenue ($m), 2004 - 2011
• Table 12: Diagnostic Imaging Market, China, Revenue ($m), 2011 - 2018
• Table 13: Diagnostic Imaging Market, China, Key Company Revenue ($m), 2011
• Table 14: Cardiovascular Devices Market, China, Revenue ($m), 2004 - 2011
• Table 15: Cardiovascular Devices Market, China, Revenue ($m), 2011 - 2018
• Table 16: Cardiovascular Devices Market, China, Key Company Share ($m), 2011
• Table 17: Nephrology and Urology Devices Market, China, Revenue ($m), 2004 - 2011
• Table 18: Nephrology and Urology Devices Market, China, Revenue ($m), 2011 - 2018
• Table 19: Nephrology and Urology Devices Market, China, Key Company Revenue ($m), 2011
• Table 20: Orthopedic Devices Market, China, Revenue ($m), 2004 - 2011
• Table 21: Orthopedic Devices Market, China, Revenue ($m), 2011 - 2018
• Table 22: Orthopedic Devices Market, China, Key Company Revenue ($m), 2011
• Table 23: Drug Delivery Devices Market, China, Revenue ($m), 2004 - 2011
• Table 24: Drug Delivery Devices Market, China, Revenue ($m), 2011 - 2018
• Table 25: Drug Delivery Devices Market, China, Key Company Revenue ($m), 2010
• Table 26: Diabetes Care Devices Market, China, Revenue ($m), 2004 - 2011
• Table 27: Diabetes Care Devices Market, China, Revenue ($m), 2011 - 2018
• Table 28: Diabetes Care Devices Market, China, Key Company Share ($m), 2011
• Table 29: Wound Care Management Market, China, Revenue ($m), 2004 - 2011
• Table 30: Wound Care Management Market, China, Revenue ($m), 2011 - 2018
• Table 31: Wound Care Management Market, China, Key Company Revenue ($m), 2010
• Table 32: Healthcare IT Market, China, Revenue ($m), 2004 - 2011
• Table 33: Healthcare IT Market, China, Revenue ($m), 2011 - 2018
• Table 34: Healthcare IT Market, China, Key Company Revenue ($m), 2011
• Table 35: Siemens Healthcare, Key Products Marketed
• Table 36: Fresenius Medical Care, Key Products Marketed
• Table 37: GE Healthcare, Key Products Marketed
• Table 38: F. Hoffmann-La Roche Ltd., Key Products Marketed
• Table 39: Philips Healthcare, Key Marketed Products, China
• Table 40: Essilor International, Key Marketed Products, China
• Table 41: DePuy, Inc., Key Marketed Products, China
• Table 42: Medtronic, Key Marketed Products, China
• Table 43: Boston Scientific Corporation, Key Marketed Products, China
• Table 44: Mindray Medical International Limited, Key Products Marketed
• Table 45: Shandong Weigao, Key Products Marketed
• Table 46: Neusoft Medical Systems, Key Products Marketed
• Table 47: Vysis ALK Break Apart FISH Probe Kit, Product Status, 2012
• Table 48: OvPlex, Product Status, 2012
• Table 49: Rheonix CARD HPV Assay, Product Status, 2012
• Table 50: Premier Hb9210 Analyser, Product Status, 2012
• Table 51: Firehawk Drug Eluting Stent, Product Status, 2012
• Table 52: Hercules Balloon Catheter, Product Status, 2012
• Table 53: XTRA Autotransfusion System, Product Status, 2012
• Table 54: MIT-P-I, Product Status, 2012
• Table 55: Koning Breast CT, Product Status, 2012
• Table 56: Medical Devices Market, China, Pipeline Products - Part 1, 2012
• Table 57: Medical Devices Market, China, Pipeline Products - Part 2, 2012
• Table 58: Medical Devices Market, China, Pipeline Products - Part 3, 2012
• Table 59: Medical Devices Market, China, Pipeline Products - Part 4, 2012

Medical Devices Market in China to 2018 - Government Reforms Aimed at Strengthening the Healthcare System and Expanding Access will Accelerate Growth published by GBI Research in November 9, 2012. This report consists of Pages: 131 and the price starts from US $ 3500.

The contents of this page may be different from the latest version. Please contact us for details.

Press Release

Medical Devices Market in China Forecast to Increase at CAGR of 11% Reaching $30.4 bn in 2018 - Government Reforms Aimed at Strengthening Healthcare System and Expanding Access will Accelerate Growth

Global Information Inc. would like to present a new market research report, "Medical Devices Market in China to 2018 - Government Reforms Aimed at Strengthening the Healthcare System and Expanding Access will Accelerate Growth" by GBI Research.

The medical devices market in China is forecast to grow at a Compound Annual Growth Rate (CAGR) of 11%, from $14.3 billion in 2011 to reach $30.4 billion in 2018.

A large population with a high percentage of elderly people, the rising incidence of chronic diseases and the countrys improving healthcare infrastructure are major driving factors for the medical devices market in China. Chinas healthcare reforms are focused on improving the countrys healthcare services, with emphasis on improving the rural healthcare system. Improvements in the countrys healthcare infrastructure due to healthcare reforms and stimulus spending are expected to drive the market growth for both international and domestic companies. Growth drivers include factors such as improved affordability and accessibility of healthcare services, and increased demand for medical devices and equipment due to an increase in the number of hospitals. As the new insurance policies aim to increase the reimbursement ratio for a number of diseases, an expanding patient base will result in significant growth opportunities for the medical device manufacturers in the country.

Healthcare Reforms in China: A Major Driving Force behind Chinas Healthcare Sector

The establishment of healthcare reforms through an initiative called Opinions on Deepening the Health Care System Reform, also known as the New Health Care Reform Plan, by the Chinese State Council and the Communist Party of China (CPC) Central Committee, is the major driving factor for the healthcare sector in China. The series of initiatives planned by the government were aimed towards providing a health service system for both the urban and rural population. These initiatives work towards addressing the limitations of the market-oriented Chinese economy and strengthening the countrys healthcare system.

These policies are instrumental not only in improving the healthcare system in China, but are also providing huge growth opportunities to medical device companies that expect to utilize the market potential offered by the lucrative Chinese medical devices market.

The Ophthalmic Devices and In Vitro Diagnostics Sectors are the Largest in the Medical Devices Market in China

Chinas medical devices market is dominated by the ophthalmic devices and In Vitro Diagnostics (IVD) sectors, accounting for a significant market share in the medical devices market in China. Increasing life expectancy and growing incidence of ophthalmic diseases, especially in the elderly population, are major factors driving the demand for ophthalmic devices in China. China has a large population of patients suffering from cataracts, with a large number of cases being added annually. Despite a large patient pool, the country still suffers from a low Cataract Surgery Rate (CSR), due to lack of facilities in the rural areas, limited awareness about cataract surgeries and the high cost of these surgeries. However, with the implementation of the government-backed insurance schemes, and a subsequent increase in the reimbursement ratio (the ratio of the total amount reimbursed) there is expected to be a significant demand for the adoption of ophthalmic surgery devices.

The IVD market in China is driven by a large patient pool that requires large volumes of tests. Improving affordability for both the urban and rural population is expected to accelerate the growth of IVD products in China. Rapid urbanization and economic development has resulted in lifestyle and nutritional changes among the population, leading to an increase in the incidence of conditions such as diabetes and cardiovascular diseases. There has also been a rise in the cases of infectious diseases, with nearly 15,802 deaths in 2011 due to infectious disease.